glp-1 stimulation Trends in the Development of Receptor Agonists Mechanisms of Action and Therapeutic

Ethics declarations Ethics approval and consent to participate Our research adhered to the tenets of the Declaration of Helsinki

second, focusing on high-risk cohorts, such as patients with MASH-related compensated cirrhosis, using dynamic contrast-enhanced ultrasound (DCE-US) to monitor de novo nodule emergence and evolution (e.g., arterial phase hyperenhancement) as surrogate endpoints for preliminary chemopreventive assessment

United Eur

Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study

Weighing In on Obesity and Psoriatic Arthritis Time to Move Beyond Association to Robust Randomised Trials

Safety considerations: can lupus patients take tirzepatide